Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Do not make the mistake of considering psoriasis as dandruff. It is important to know the difference between scalp psoriasis ...

What is Trichodynia?Trichodynia, often called scalp dysesthesia, is a condition marked by discomfort or pain in the scalp.

Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to ...

The scalp microbiome comprises diverse bacteria, fungi, and yeast that interact with sebum, pH, and immune responses to ...

Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and ...

Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

The primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin.

Once-daily roflumilast foam significantly improves scalp and body psoriasis in 8 weeks and was well-tolerated in adolescents ...

Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.